Validated QPS Assays
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno-bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
Search For An Assay Here
CYP2D6 (*4, *9, *15, *17, *18, *19, *20, *29, *35, *38, *40, *41) Genotyping; Copy Number Variation (*5/*2xN)
Matrix: | Human Whole Blood |
Assay Range: | N.Ap. |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -80 |
Platform: | TaqMan; 7900 |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Genomic Biomarkers |
CYP3A4 (*1B, *2, *3) Genotyping
Matrix: | Human Whole Blood |
Assay Range: | N.Ap. |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -80 |
Platform: | Pyrosequencing |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Genomic Biomarkers |
CYP3A5 (*3C, *6) Genotyping
Matrix: | Human Whole Blood |
Assay Range: | N.Ap. |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -80 |
Platform: | Pyrosequencing |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Genomic Biomarkers |
Cystatin C
Matrix: | Human Urine |
Assay Range: | 3.13 - 100 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | ELISA |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Genomic Biomarkers |
Cystatin C
Matrix: | Human Serum |
Assay Range: | 3.13 - 100 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | ELISA |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Cystatin C
Matrix: | Human Serum |
Assay Range: | 3.12 - 50 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -70 |
Platform: | ELISA |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Cystatin C
Matrix: | Human Urine |
Assay Range: | 3.12 - 50 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -70 |
Platform: | ELISA |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Cystatin C
Matrix: | Human Serum |
Assay Range: | 0.156 - 3,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -70 |
Platform: | ELISA |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Cystatin C
Matrix: | Human Urine |
Assay Range: | 1.56 - 400 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -70 |
Platform: | ELISA |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Cystatin C
Matrix: | Human Plasma |
Assay Range: | 2 - 100 ng/mL |
Sample Volume: | 0.01 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | ELISA |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Cytidine Deaminase, CDA(79A>C, 208G>A, 435C>T) Genotyping
Matrix: | Human Whole Blood |
Assay Range: | N.Ap. |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -80 |
Platform: | Pyrosequencing |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Genomic Biomarkers |
Cytokine Panel: MSD ProInflammatory 10-Plex
Matrix: | Human Plasma |
Assay Range: | varies per cytokine |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | ECL (MSD) (10plex) |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Cytokine Panel: MSD ProInflammatory 10-Plex
Matrix: | Human CSF |
Assay Range: | varies per cytokine |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | ECL (MSD) (10plex) |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
d-Amphetamine l-Amphetamine
Matrix: | Human Plasma |
Assay Range: | 0.1 - 100 ng/mL0.1 - 100 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Stimulant |
Classification: | Drug Assays |
Dabigatran (Free)
Matrix: | Human Plasma |
Assay Range: | 1 - 300 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Dabigatran (Total)
Matrix: | Human Plasma |
Assay Range: | 1 - 500 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Daclatasvir
Matrix: | Human Plasma |
Assay Range: | 10 - 3000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antiviral - HCV |
Classification: | Drug Assays |
Dalteparin Sodium (anti-Factor IIa)
Matrix: | Human Plasma |
Assay Range: | 1.0 - 8.0 µg/mL |
Sample Volume: | 0.025 mL |
Anti-Coagulant: | Citrate |
Storage Temperature (°C): | -70 |
Platform: | Activity / Colorimetric |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Dalteparin Sodium (anti-Factor Xa)
Matrix: | Human Plasma |
Assay Range: | 1.0 - 10.0 µg/mL |
Sample Volume: | 0.025 mL |
Anti-Coagulant: | Citrate |
Storage Temperature (°C): | -70 |
Platform: | Activity / Colorimetric |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Dapagliflozin in presence of Metformin
Matrix: | Human Plasma |
Assay Range: | 1 - 400 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC-MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Anti-diabetic |
Classification: | Drug Assays |
Dapagliflozin in presence of Saxagliptin and 5-OH-saxagliptin
Matrix: | Human Plasma |
Assay Range: | 1 - 400 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Anti-diabetic |
Classification: | Drug Assays |
Dapsone
Matrix: | Human Plasma |
Assay Range: | 5 - 5,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antibiotic |
Classification: | Drug Assays |
Dapsone
Dapsone Hydroxyamine
Dapsone Hydroxyamine
Matrix: | Human Urine |
Assay Range: | 50 - 3,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antibiotic |
Classification: | Drug Assays |
Dapsone
N-Acetyldapsone
N-Acetyldapsone
Matrix: | Human Plasma |
Assay Range: | 10 - 3,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antibiotic |
Classification: | Drug Assays |
Dapsone
N-Acetyldapsone
N-Acetyldapsone
Matrix: | Human Plasma |
Assay Range: | 10 - 3,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antibiotic |
Classification: | Drug Assays |
Links to Relevant Documents
Testimonials
Thanks for the good news, I’m happy to see that within less than a month you will have developed and validated the assay. Good Job!
QPS CLIENT